Azenta reported a strong first quarter for fiscal year 2023, with revenue reaching $178 million, a 28% increase year-over-year. Organic growth, excluding COVID impacts, was 7%. The company has also begun efforts to streamline its business structure to enhance operational efficiency.
Achieved revenue of $178 million, marking a 28% year-over-year increase.
Experienced 7% organic growth, excluding the impact of COVID-19.
Initiated actions to streamline business structure for efficiency.
Integration of B Medical is well under way and momentum continues in many areas across the business.
The Company announced revenue and earnings guidance for the second quarter fiscal 2023. Revenue is expected to be in the range of $156 to $171 million and non-GAAP diluted earnings per share is expected to be in the range of ($0.04) to $0.04. GAAP diluted earnings per share from continuing operations is expected to be in the range of ($0.24) to ($0.16).